Back to 
Royal Bank of Canada
Royal Bank of Canada
INBX
9 quarters
Position history for Royal Bank of Canada's holdings in Inhibrx Biosciences, Inc.
Yes. Royal Bank of Canada holds 386 shares of INBX (Inhibrx Biosciences), worth $36,000, as of its Q2 2026 13F filing. It increased the position from 107 shares in Q1 2026. Royal Bank of Canada has held INBX in every 13F on record since Q2 2024, 9 quarterly filings.
Current Value
$36,000
Current Shares
386
Total Value Change
+$21,000
Total Shares Change
-695
Quarter-by-Quarter History
Other major holders of INBX: Morgan Stanley, Viking Global Investors LP